| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.04 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.083 | 0.04 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.28 | 0.04 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.04 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.05 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |